Hélène Tribodet

4.2k total citations · 2 hit papers
8 papers, 2.6k citations indexed

About

Hélène Tribodet is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Hepatology. According to data from OpenAlex, Hélène Tribodet has authored 8 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Hepatology. Recurrent topics in Hélène Tribodet's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Hélène Tribodet is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Hélène Tribodet collaborates with scholars based in France, United Kingdom and Canada. Hélène Tribodet's co-authors include Jean‐Pierre Pignon, Richard Stephens, Thierry Le Chevalier, Frances A. Shepherd, Giorgio V. Scagliotti, Stephen Spiro, Lesley Seymour, Jean-Yves Douillard, Keyue Ding and D. Aubert and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Hélène Tribodet

8 papers receiving 2.6k citations

Hit Papers

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by ... 2008 2026 2014 2020 2008 2010 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
    2008 1.8k citations Jean‐Pierre Pignon, Hélène Tribodet et al. Journal of Clinical Oncology profile →
  2. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
    2010 444 citations R. Arriagada, A. Aupérin et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hélène Tribodet France 6 2.3k 1.3k 375 315 283 8 2.6k
D. Aubert France 11 1.8k 0.8× 1.2k 0.9× 287 0.8× 279 0.9× 254 0.9× 31 2.2k
Oana Petrenciuc United States 16 1.0k 0.4× 779 0.6× 503 1.3× 335 1.1× 552 2.0× 36 1.6k
Zhouguang Hui China 22 1.1k 0.5× 575 0.4× 378 1.0× 217 0.7× 256 0.9× 145 1.7k
Purvish Parikh India 9 2.1k 0.9× 1.8k 1.4× 99 0.3× 412 1.3× 521 1.8× 21 2.6k
Pasquale Comella Italy 17 780 0.3× 1.2k 0.9× 175 0.5× 150 0.5× 249 0.9× 55 1.6k
Jean Louis Pujol France 16 1.3k 0.6× 1.1k 0.9× 122 0.3× 123 0.4× 281 1.0× 35 1.8k
Maria Rita Migliorino Italy 17 1.8k 0.8× 1.6k 1.2× 100 0.3× 330 1.0× 511 1.8× 40 2.3k
E.H. Tan Singapore 8 2.0k 0.9× 1.8k 1.4× 92 0.2× 367 1.2× 544 1.9× 23 2.4k
Cesare Gridelli Italy 18 2.4k 1.0× 2.1k 1.6× 60 0.2× 270 0.9× 527 1.9× 37 2.9k

Countries citing papers authored by Hélène Tribodet

Since Specialization
Citations

This map shows the geographic impact of Hélène Tribodet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Tribodet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Tribodet more than expected).

Fields of papers citing papers by Hélène Tribodet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Tribodet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Tribodet. The network helps show where Hélène Tribodet may publish in the future.

Co-authorship network of co-authors of Hélène Tribodet

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Tribodet. A scholar is included among the top collaborators of Hélène Tribodet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Tribodet. Hélène Tribodet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Douillard, Jean-Yves, Hélène Tribodet, D. Aubert, et al.. (2010). Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation. Journal of Thoracic Oncology. 5(2). 220–228. 183 indexed citations
2.
Arriagada, R., A. Aupérin, Sarah Burdett, et al.. (2010). Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. The Lancet. 375(9722). 1267–1277. 444 indexed citations breakdown →
3.
Früh, Martin, Estelle Rolland, Jean‐Pierre Pignon, et al.. (2008). Pooled Analysis of the Effect of Age on Adjuvant Cisplatin-Based Chemotherapy for Completely Resected Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 26(21). 3573–3581. 132 indexed citations
4.
Pignon, Jean‐Pierre, Hélène Tribodet, Giorgio V. Scagliotti, et al.. (2008). Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group. Journal of Clinical Oncology. 26(21). 3552–3559. 1752 indexed citations breakdown →
5.
6.
Péchoux, C. Le, Hélène Tribodet, Jean‐Pierre Pignon, & Sarah Burdett. (2007). Surgery (S) and radiotherapy (RT) plus adjuvant chemotherapy (CT) versus surgery and radiotherapy in non-small cell lung cancer (NSCLC): A meta-analysis using individual patient data (IPD) from randomised clinical trials (RCTs). Journal of Clinical Oncology. 25(18_suppl). 7521–7521. 9 indexed citations
7.
Bourhis, Jean, Hélène Tribodet, David M. Brizel, et al.. (2006). 117. International Journal of Radiation Oncology*Biology*Physics. 66(3). S67–S67. 5 indexed citations
8.
Pignon, Jean‐Pierre, Hélène Tribodet, Giorgio V. Scagliotti, et al.. (2006). Lung Adjuvant Cisplatin Evaluation (LACE): A pooled analysis of five randomized clinical trials including 4,584 patients. Journal of Clinical Oncology. 24(18_suppl). 7008–7008. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Aubert Breakdown of academic impact, for papers by Oana Petrenciuc Breakdown of academic impact, for papers by Zhouguang Hui Breakdown of academic impact, for papers by Purvish Parikh Breakdown of academic impact, for papers by Pasquale Comella Breakdown of academic impact, for papers by Jean Louis Pujol Breakdown of academic impact, for papers by Maria Rita Migliorino Breakdown of academic impact, for papers by E.H. Tan Breakdown of academic impact, for papers by Cesare Gridelli
Rankless by CCL
2026